TransEnterix, Inc. (NYSE:TRXC) reached 455.56% versus a 1-year low price of $0.45. The stock was last seen 4.17% higher, reaching at $2.5 on 11/24/2017. At recent session, the prices were hovering between $2.36 and $2.53. This company shares are 86.8% off its target price of $4.67 and the current market capitalization stands at $528.1M. The recent change has given its price a 11.84% lead over SMA 50 and -50% deficit over its 52-week high. The stock witnessed -19.61% declines, 208.64% gains and 431.58% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found TRXC’s volatility during a week at 7.15% and during a month it has been found around 11.87%.TransEnterix, Inc. (TRXC) Top Holders
Institutional investors currently hold around $93 million or 22.9% in TRXC stock. Look at its top three institutional owners. Aisling Capital Llc owns $24.81 million in TransEnterix, Inc., which represents roughly 4.7% of the company’s market cap and approximately 26.67% of the institutional ownership. Similar statistics are true for the second largest owner, Sv Health Investors, Llc, which owns 7,546,692 shares of the stock are valued at $18.11 million. The third largest holder is Jpmorgan Chase & Co, which currently holds $10.15 million worth of this stock and that ownership represents nearly 1.92% of its market capitalization.
At the end of 09/30/2017 reporting period, 26 institutional holders increased their position in TransEnterix, Inc. (NYSE:TRXC) by some 2,139,729 shares, 26 decreased positions by 6,709,148 and 19 held positions by 29,956,834. That puts total institutional holdings at 38,805,711 shares, according to SEC filings. The stock grabbed 6 new institutional investments totaling 154,490 shares while 11 institutional investors sold out their entire positions totaling 5,209,918 shares.TransEnterix, Inc. (NYSE:TRXC) Insider Trades
Multiple company employees have indulged in significant insider trading. TransEnterix, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that EVP and CFO Slattery Joseph P has sold 529,609 shares of TransEnterix, Inc. (TRXC) in trading session dated Nov. 16, 2017. These shares are worth $1,482,905 and were traded at $2.8 each. The SEC filing shows that Pope Todd performed a sale of 600,000 shares. The President and CEO disposed these shares by way of transaction on Oct. 18, 2017. The company’s shares were given away at $3.68 per share worth to an income of some $2,208,000 on account of Pope Todd.
Director, Kelley Willam N, purchased 30,000 common shares of TransEnterix, Inc. (TRXC) in the open market. In a transaction dated Aug. 08, 2017, the shares were bought at an average price of $0.71, giving away a sum of $21,300. After this purchase, 50,000 common shares of TRXC are directly owned by the insider, with total stake valued at $125,000.
In the transaction dated May. 16, 2017, the great number of shares acquired came courtesy the Director; Pfenniger Richard C Jr added a total of 100,000 shares at an average price of $0.54, amounting to approximately $54,000. The insider now directly owns 148,000 shares worth $370,000.TransEnterix, Inc. (TRXC) Analyst Guide
Several analysts have released their opinion on TransEnterix, Inc. (NYSE:TRXC), with 2 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.67 average brokerage recommendation.